|
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
RECRUITINGSponsored by Helmholtz Zentrum München
Actively Recruiting
SponsorHelmholtz Zentrum München
Started2017-10-19
Est. completion2027-08
Eligibility
Age1 Day – 6 Weeks
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT03316261
Summary
The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.
Eligibility
Age: 1 Day – 6 WeeksHealthy volunteers accepted
Inclusion Criteria: * Age: up to age 6 weeks * provided written informed consent by custodial parent Exclusion Criteria: \-
Conditions2
DiabetesIdentification of Infants at Risk for Type 1 Diabetes
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorHelmholtz Zentrum München
Started2017-10-19
Est. completion2027-08
Eligibility
Age1 Day – 6 Weeks
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT03316261